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ABSTRACT 
The present study was carried out to evaluate the optimum Production of Rifamycin B by using fed- batch mode in the shake flask at 
the defenit level of different agitation and aeration rate, amongst different carbohydrate in the form of monoshacride. Amongst the 
various carbohydrate (Arabinose, Fructose, Galactose, Glucose, Glycerol, Maltose, Mannitol, Sorbitol, and Sucrose) sources 
maximum, the rifamycin (578 µgml-1) with 10% glucose level was found as compared to control which was (138 ± 2.70µgml-1).The 
environmental factors such as incubation temperature. The optimum temperature for maximum antibiotic production (525µgml-1) 
was found to be 29°C, initial pH, aeration and agitation rates were also optimized. The optimum rifamycin yield (950 to 1100µgml-1) 
was obtained in 1.0 L fermenter with working volume of 1.5 L at 28 °C with initial pH of 6.2 to 6.5. The agitation and aeration were 
300 rpm and 0.5 LL-1 min-1respectively. 
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INTRODUCTION  
One of the purposes of fed-batching is to make the 
substrate(s) available to the microorganism at an 
optimum concentration for a longer period of time or at 
specified times of the process. In the fed-batch mode, 
gradual addition of concentrated additives, e.g. nutrients, 
takes place. Fed-batch cultures can be used for 
fermentation processes in which the products are either 
growth associated or non-growth associated. In the 
course of the development of the fermentation process 
for production of rifamycin B, fed-batch fermentations 
have been developed in order to extend the production 
phase, where sources of sugar, organic and inorganic 
nitrogen were fed -batch wise or continuously
1
. The 
bacterial culture of Nocardia mediterranea ATCC 
13865 was used for production of ant tubercular 
antibiotic rifamycin by submerged fermentation 
procedure. In previous (Ist paper reference).The culture 
was improved by sequential mutagenic treatment with 
NTG (N-methyl-N' -nitro-N-nitroso- guanidine) and U.V 
radiation. The mutant strain was designed as Nocardia 
Mediterranea M-120. Carbohydrates in the form of 
monosaccharide’s and disaccharides were employed for 
the production of rifamycin. Among all sugars glucose 
(9.5%w/v) gave the maximum yield of antibiotic 
2-5
. 
MATERIAL AND METHOD 
Bacterial strains 
Nocardia mediterranea ATCC 13865 was obtained from 
American type culture collection centre, USA and 
maintained on agar slants of medium containing (gl
-1
) 
peptone-6, yeast extract-3, beef extract-1.5, dextrose-1, 
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agar-15,pH-6.6 . Used for production of antibiotic 
rifamycin.  
Stock culture 
Pure and high yielding culture of Nocardia mediterranea 
ATCC 13865 was used for the production of antibiotic, 
rifamycin B. The culture was maintained on ML-
sporulating agar medium (mineral base lactose medium) 
as described by figure 1. The ingredients were dissolved 
in distilled water. The pH of the medium was adjusted 
with NaOH or HC1. All the media unless otherwise 
stated were autoclaved at 121°C for 15 minutes. Slants 
were incubated at 28°C for 5 days for sporulation and 
then stored in the refrigerator at 4°C for further use 
(O.M., 2004). Sub culturing was made after every four 
night. The culture was improved by sequential 
mutagenic treatment with nitrosoguanidine (N.T.G) and 
UV irradiation and the selection was based on increasing 
concentrations of rifamycin B in shake flasks 
6,7
.  
Fermentation medium  
The initial fermentation medium for fermentation 
experiments containing (gl
-1
) Glucose- 94, Soybean 
meal- 10, Peanut meal- 21.4, CaC03- 9.5, KH2P04- 0.4, 
MgS047H20- 1.0, Barbital- 2.0, Glucose- 70, Peptone- 
30, Glycerol- 20, CaC03- 8.0, KH2P04- 19, MgS047H20- 
1.0, Barbital- 2.0, (NH4)2S04- 3.0, (NH4)2S04- 8.0, 
CuS04.5H20- 0.0165, ZnS04.7H20- 0.004, FeS04.2H20- 
0.002, MnS04.4H20- 0.001 .was used and various other 
method as age and size inoculums ,UV irradiation .Other 
chemical such as glucose, ammonium sulphate, KH2P04 
and calcium carbonate etc. were of analytical grade. 
Fermentation experiment were conducted in 250ml. 
shake flask with 50ml. medium for a period of 12 days 
by changing the various concentration of media 
component and optimizing the cultural condition of the 
strain to improve the rifamycin production
10,11
 .  
RESULT AND DISCUSSION 
Production of Rifamycin 
Effect of incubation temperature 
The influence of incubation temperature on rifamycin B 
production was investigated by cultivating Nocardia 
mediterranea in medium M-6 at different levels of 
temperature. Initially rifamycin production was 
enhanced with the rise in temperature. The optimum 
temperature for maximum antibiotic production was 
found to be 29°C. An increase or decrease further in the 
temperature reduced the yield of antibiotic indicating 
that the bacterium is sensitive to temperature in many 
reports the optimum temperature for rifamycin B 
fermentation is given as 29 °C
12
. 
 
 
Figure 1: Effect of incubation temperature on the production of rifamycin 
 
 Effect of aeration 
The availability of oxygen to the microbes during 
fermentation plays important role for the synthesis of 
secondary metabolites. In order to compare the effect of 
aeration on the bacterial cell mass and rifamycin 
production, the different volumes such as 25, 50, 75, 
100, and 125 ml of the medium M-6 was taken into 250 
ml flask. After incubation the fermentation was carried 
out for 120 hours. The shake flasks used had the same 
size and form and shaking was done under the same 
conditions. The lesser the volume of the medium present 
in the flask, the higher was the oxygen supply to the 
culture. The rifamycin potency was slightly increased 
from 350 to 362µgml
-1 
when volume of the medium in 
flasks was changed from 25ml to 50ml and percent 
mycelia volume (PMV) varied from 24 to 26 %. Both 
the rifamycin production and cell biomass adversely 
affected when the volume was increased beyond 50 
ml/flask
3
. 
The rifamycin yield was only 191 µgml
-1 
and cell 
biomass formation was poor (PMV) when 125 ml of the 
medium was present in the flask. The shaking of flasks 
on rotary mechanical shaker provided aeration for the 
microorganism. The rifamycin production was maximal 
when 50 ml of fermentation medium was present in the 
flask. Further increase resulted in the volume in 
lowering the antibiotic production due to lesser 
agitation, which in turn resulted in to poor oxygen 
supply to the culture. The optimum volume of 
production medium (50ml/250ml) flask is in accordance 
with the studies of BM
4, 8
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Figure 2: Effect of aeration on the production of rifamycin 
Effect of aeration and agitation 
The availability of oxygen to the microbes during 
fermentation is very critical for the synthesis of enzymes 
or metabolites. Only dissolved oxygen becomes 
available to the microbes for its propagation in 
metabolites formation. To investigate the effect of 
aeration on the production of antibiotic rifamycin B, a 
series of batch cultures were run using Nocardia 
mediterranea M-120. The rate of agitation was set at 
200, 300 and 500 rpm with different rates aeration (1.0 
to 2.0 LL
-1
min.
-1
) 
9
. During the course of fermentation, 
pH, residual glucose, cell biomass and antibiotic 
potency were estimated. In this processes the optimum 
rifamycin yield (949 to 1100µgml
-1
) was obtained in 1.0 
L fermenter with working volume of 1.5 L at 28 °C with 
initial pH of 6.2 to 6.5. The agitation and aeration were 
300 rpm and 1.0 LL
-1 
min.
-1
respectively. 
 
 
Figure 3: Effect of aeration on the production of Rifamycin B by nocardia mediterranea M-120 at 200 rpm 
 
Figure 4: Effect of Aeration on the Production of Rifamycin B By Nocardia Mediterranea M-120 at 300 Rpm 
Effect of carbohydrates 
An adequate supply of the carbon energy source is 
critical for optimal growth and production formation. 
The culture Nocardia mediterranea M-120 was 
cultivated in the basal medium M-6 deleting glucose. 
The effect of different carbohydrates such as glucose, 
lactose, fructose, sucrose, maltose and glycerol etc on 
the production was investigated in the basal medium. 
Each carbon source was added separately at a 
concentration of 5%, 7.5% and 10% (w/v) to the 
fermentation medium before sterilization in all the 
experiments to investigate their effect on the rifamycin 
production. Glucose showed the highest production of 
antibiotic (578 µgml
-1
). Fructose also stimulated the 
rifamycin production to a lesser extent as compared to 
glucose. The antibiotic activity was maximal in the 
presence of 10% glucose (578 µgml
-1
) and 10% fructose 
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(489 µgml
-1
). While sucrose, sorbital, galactose and 
maltose were less effective. 
Addition of xylose, lactose or starch even decreased the 
antibiotic production. The control basal medium without 
any sugar gave 138 µgml
-1 
rifamycin B. It follows that 
defatted meals also provide nutrients both for bacterial 
growth and antibiotic production. The addition of sugar 
however, increases the synthesis of antibiotic.
 
Figure 5: Effect of Aeration on the Production of Rifamycin B by Nocardia Mediterranea M-120 at 500 Rpm
 
Figure 6: Effect of different carbohydrates on the production of rifamycin 
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